Current and future prospects of integrating traditional and alternative medicine in the management of diseases in Tanzania

Traditional medicine and medicinal plants, in general, continue to be a powerful source of new drugs, now contributing about 90% of the newly discovered pharmaceuticals. Traditional medicine continues to provide health coverage for over 80% of the world population, especially in the developing world. The past and the present are all full of living examples of discoveries of drugs, ranging from anticancer, antiasthma, antidiabetic, antihypertensives and many others which owe their origin to traditional medicine. The current era of HIV/AIDS is not short of contributions from traditional medicine. The recent discovery of the non-nucleoside reverse transcriptase inhibitor (NNRTI), calanolide A, is a new addition from traditional medicine. Many more such discoveries are yet to come. While this potential is much acknowledged, little has been done in African countries, to utilize the plants that are already known and proven to be safe for use by patients. A number of plants could be widely cultivated for local industrial production of medicines and herbal nutritional supplements. There is need to ensure that what is known is made use of, for financial gain, and for improvement of the health of our people. We need to establish the necessary expertise for development of traditional medicines and deliberate efforts should be made to encourage local industrial production of traditional/herbal medicines so that cultivation may become possible and hence contribute to poverty reduction. Keywords: traditional medicine, alternative medicine, diseases, Tanzania Tanzania Health Research Bulletin Vol. 7(3) 2005: 159-16

The Effect of Phyllanthus Amarus Aqueous Extract on Blood Glucose in Non-Insulin Dependent Diabetic Patients

The glycaemic response to 124.5 ± 9.3 (mean ± SD) g of pancakes was monitored in 21 non-insulin dependent diabetic (NIDDM) patients while on oral hypoglycaemics, after a one week washout period and after a one week twice daily treatment with 100 ml of an aqueous extract from 12.5 g of powdered aerial parts of Phyllanthus amarus. After the one week washout period, fasting blood glucose (FBG) and postprandial blood glucose increased significantly compared to when on oral hypoglycaemics (P ≤ 0.05). After one week herbal treatment no hypoglycaemic activity was observed. Both FBG and postprandial blood glucose remained very similar to that recorded after the washout period (P > 0.05). Both liver and renal functions based on alanine transaminase (ALAT) and serum creatinine, respectively, were not significantly affected by the use of the extract. Although lymphocyte and monocyte levels were significantly decreased (P ≤ 0.05) and granulocyte level was significantly increased after treatment (P ≤ 0.05) overall total white blood cell (WBC) count and haemoglobin (Hb) were not significantly affected by the one week herbal treatment. We conclude that one week treatment with the aqueous extract of Phyllanthus amarus was incapable of lowering both FBG and postprandial blood glucose in untreated NIDDM patients

Brine shrimp lethality of a glutarimide alkaloid from Croton sylvaticus Hochst

No Abstract.The East and Central African Journal of Pharmaceutical Sciences Vol. 8(1) 2005: 3-

Cytotoxic Screening of Some Tanzania Medicinal Plants

East and Central African Journal of Pharmaceutical Sciences Vol.6(3) 2003: 52-5

Anticonvulsant Activity Of Diospyros fischeri Root Extracts

Diospyros fischeri Gurke (Ebenaceae) is used in traditional medicine for the treatment of epilepsy. Dichloromethane, ethylacetate, and ethanol extracts of the roots, at doses between 100 and 1600 mg/kg BW,  inhibited convulsions induced by the γ‐aminobutyric acid type A (GABAA) receptor antagonist, pentylenetetrazole (PTZ), in a dose dependent manner. The extracts also exhibited low toxicity against brine shrimps giving LC50 values between 45 .4 and 95.4 μg/ml.  These results provide evidence for the potential of D. fischeri extracts to treat absence seizures, especially given their seemingly innocuous nature. Keywords: Diospyros fischeri; Pentylenetetrazole; Anticonvulsant activity; Brine shrimp toxicity African Journal of Traditional, Complementary and Alternative Medicines Vol. 4 (2) 2007: pp. 226-23

Antimicrobial activity and brine shrimp toxicity of extracts of Terminalia brownii roots and stem

BACKGROUND: Ternimalia brownii Fresen (Combretaceae) is widely used in traditional medicine to treat bacterial, fungal and viral infections. There is a need to evaluate extracts of this plant in order to provide scientific proof for it's wide application in traditional medicine system. METHODS: Extraction of stem bark, wood and whole roots of T. brownii using solvents of increasing polarity, namely, Pet ether, dichloromethane, dichloromethane: methanol (1:1), methanol and aqua, respectively, afforded dry extracts. The extracts were tested for antifungal and antibacterial activity and for brine shrimp toxicity test. RESULTS: Extracts of the stem bark, wood and whole roots of T. brownii exhibited antibacterial activity against standard strains of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella typhi, and Bacillus anthracis and the fungi, Candida albicans and Cryptococcus neoformans. Aqueous extracts exhibited the strongest activity against both bacteria and fungi. Extracts of the roots and stem bark exhibited relatively mild cytotoxic activity against brine shrimp larvae with LC(50 )values ranging from 113.75–4356.76 and 36.12–1458.81 μg/ml, respectively. The stem wood extracts exhibited the highest toxicity against the shrimps (LC(50 )values 2.58–14.88 μg/ml), while that of cyclophosphamide, a standard anticancer drug, was 16.33 (10.60–25.15) μg/ml. CONCLUSION: These test results support traditional medicinal use of, especially, aqueous extracts for the treatment of conditions such as diarrhea, and gonorrhea. The brine shrimp results depict the general trend among plants of the genus Terminalia, which are known to contain cytotoxic compounds such as hydrolysable tannins. These results warrant follow-up through bioassay-directed isolation of the active principles

Brine shrimp toxicity of some plants used as traditional medicines in Kagera Region, north western Tanzania

Dichloromethane and/or ethanol extracts of 30 plants used as traditional medicines in Bukoba district, northwestern Tanzania were evaluated for brine shrimp toxicity. Among the 50 extracts tested, 32 extracts (64%) showed very low toxicity with LC50 values above 100 μg/ml. Among these 12 (24%) which had LC50 >500 μg /ml can be categorized as being practically non‐toxic. Among the remaining extracts 19 (38%) which showed LC50 >100 < 500 μg /ml are also considered to be nontoxic. Extracts that showed LC50 results between 30‐100 μg/ml have been categorized as mildly toxic; these include ethanol extracts of Lantana trifolia (LC50 32.3 μg/ml), Vernonia bradycalyx (LC50 33.9 μg/ml), Antiaris toxicaria (LC50 38.2 μg /ml) and Rubus rigidus (LC50 41.7 μg /ml) and the dichloromethane extracts of Gynura scandens (LC50 36.5 μg /ml) and Bridelia micrantha (LC50 32.0 μg /ml). The dichloromethane extracts of Picralima nitida (LC50 18.3 μg/ml) and Rubus rigidus (LC50 19.8 μg /ml), were only moderately toxic. Picralima nitida and Rubus rigidus extracts are only 1.1 and 1.2 less toxic than the standard drug, cyclophosphamide (LC50 16.3 μg /ml). In conclusion, the results indicate that among the 30 plants used as traditional medicines, 28 are safe for short term use. Picralima nitida and Rubus rigidus extracts are mildly toxic, but by comparison have a remote possibility to yield active anticancer compoundsTanzania Journal of Health Research Volume (2010) 12(1

Brine Shrimp Toxicity Evaluation Of Some Tanzanian Plants Used Traditionally For The Treatment Of Fungal Infections

Plants which are used by traditional healers in Tanzania have been evaluated to obtain preliminary data of their toxicity using the brine shrimps test. The results indicate that 9 out of 44 plant species whose extracts were tested exhibited high toxicity with LC50 values below 20&#956;g/ml. These include Aloe lateritia Engl. (Aloaceae) [19.1&#956;g/ml], Cassia abbreviata Oliv. (Caesalpiniaceae) [12.7&#956;g/ml], Croton scheffleri Pax (Euphorbiaceae) [13.7&#956;g/ml], Hymenodactyon parvifolium Brig (Rubiaceae) [13.4&#956;g/ml], Kigelia Africana L. (Bignoniaceae) [7.2&#956;g/ml], and Ocimum suave Oliv. (Labiatae) [16.7&#956;g/ml]. Twelve plants gave LC50 values between 21 and 50&#956;g/ml, 11 plants gave LC50 values between 50 and 100 &#956;g/ml, and 18 plants gave LC50 values greater than 100 &#956;g/ml. Keywords: Brine shrimp test; Toxicity evaluation; Traditional antifungal plants African Journal of Traditional, Complementary and Alternative Medicines Vol. 4 (2) 2007: pp. 219-22

Antimicrobial Activity, Acute Toxicity and Cytoprotective Effect of Crassocephalum Vitellinum (Benth.) S. Moore Extract in a Rat Ethanol-HCl Gastric Ulcer Model.

A decoction of Crassocephallum vitellinum (Benth.) S. Moore (Asteraceae) is used in Kagera Region to treat peptic ulcers. This study seeks to evaluate an aqueous ethanol extract of aerial parts of the plant for safety and efficacy. An 80% ethanolic extract of C. vitellinum at doses of 100, 200, 400 and 800 mg/kg body wt was evaluated for ability to protect Sprague Dawley rats from acidified ethanol gastric ulceration in comparison with 40 mg/kg body wt pantoprazole. The extract and its dichloromethane, ethyl acetate, and aqueous fractions were also evaluated for acute toxicity in mice, brine shrimp toxicity, and antibacterial activity against four Gram negative bacteria; Escherichia coli (ATCC 25922), Salmonella typhi (NCTC 8385), Vibrio cholera (clinical isolate), and Streptococcus faecalis (clinical isolate). The groups of phytochemicals present in the extract were also determined. The ethanolic extract of C. vitellinum dose-dependently protected rat gastric mucosa against ethanol/HCl insult to a maximum of 88.3% at 800 mg/kg body wt, affording the same level of protection as by 40 mg/kg body wt pantoprazole. The extract also exhibited weak antibacterial activity against S. typhi and E. coli, while its ethyl acetate, dichloromethane and aqueous fractions showed weak activity against K. pneumonia, S.typhi, E. coli and V. cholera. The extract was non-toxic to mice up to 5000 mg/kg body wt, and the total extract (LC50 = 37.49 μg/ml) and the aqueous (LC50 = 87.92 μg/ml), ethyl acetate (LC50 = 119.45 μg/ml) and dichloromethane fractions (88.79 μg/ml) showed low toxicity against brine shrimps. Phytochemical screening showed that the extract contains tannins, saponins, flavonoids, and terpenoids. The results support the claims by traditional healers that a decoction of C.vitellinum has antiulcer activity. The mechanism of cytoprotection is yet to be determined but the phenolic compounds present in the extract may contribute to its protective actions. However, the dose conferring gastro-protection in the rat is too big to be translated to clinical application; thus bioassay guided fractionation to identify active compound/s or fractions is needed, and use of more peptic ulcer models to determine the mechanism for the protective action

Antibacterial, Anti-HIV-1 Protease and Cytotoxic Activities of Aqueous Ethanolic Extracts from Combretum Adenogonium Steud. Ex A. Rich (Combretaceae).

\ud \ud Records have shown that Combretum adenogonium Steud. Ex A. Rich (Combretaceae) is used in traditional medicine systems of several tribes in Tanzania. This study focused on the investigation of antibacterial activity, anti-HIV-1 protease activity, toxicity properties and classes of phytochemicals in extracts from C. adenogonium Steud. Ex A. Rich (Combretaceae) to evaluate potential of these extracts for development as herbal remedies. Dried plant material were ground to fine powder and extracted using 80% aqueous ethanol to afford root, leaf and stem bark extracts. The extracts were assayed for anti-HIV-1 protease activities, antibacterial activities using microdilution methods and cytotoxicity using brine shrimps lethality assay. Screening for major phytochemical classes was carried out using standard chemical tests. All extracts exhibited antibacterial activity to at least one of the test bacteria with MIC-values ranging from 0.31-5.0 mg/ml. Two extracts, namely, root and stem bark exhibited anti-HIV-1 PR activity with IC50 values of 24.7 and 26.5 μg/ml, respectively. Stem bark and leaf extracts showed mild toxicity with LC50 values of 65.768 μg/ml and 76.965 μg/ml, respectively, whereas roots were relatively non-toxic (LC50 = 110.042 μg/ml). Phytochemical screening of the extracts indicated presence of flavonoids, terpenoids, alkaloids, tannins, glycosides and saponins. These results provide promising baseline information for the potential development of C. adenogonium extracts in treatment of bacterial and HIV/AIDS-related opportunistic infections